Companies such as Moderna (MRNA) swung back to profits on better-than-expected revenue in Q3 thanks to its updated COVID-19 ...

The Centers for Disease Control and Prevention (CDC) recommends the Moderna and Pfizer-BioNTech COVID-19 vaccines for kids as ...

[emphasis in original] Yee cited by name Moderna (NASDAQ: MRNA) as an example of a vaccine developer hurt by declining ...

although the initial three COVID-19 vaccines didn't contain fetal cells, the Johnson & Johnson vaccine was indeed developed ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

Bank of America Securities analyst Alec Stranahan reiterated a Hold rating on Moderna (MRNA – Research Report) today and set a price ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose pre-filled syringes ...

Moderna ( (MRNA) ) has released its Q3 earnings. Here is a breakdown of the information Moderna presented to its investors. Moderna, Inc. is a ...

Health professionals recommend vaccines before traveling to celebrate the holidays with family. If you missed the early fall ...

The CDC urges both an updated COVID-19 shot and yearly flu vaccine for everyone ages 6 months and older ... The Pfizer ...